P

Inventor

GIROUX SIMON

US28 patents
⚠️ This page may combine multiple inventors who share the name “GIROUX SIMON”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

VERTEX PHARMA

27 patents
US9925188B2Mar 27, 2018

DNA-PK inhibitors and uses thereof

VERTEX PHARMA24 citations98
US9376448B2Jun 28, 2016

DNA-PK inhibitors

VERTEX PHARMA46 citations98
US9592232B2Mar 14, 2017

DNA-PK inhibitors

VERTEX PHARMA24 citations94
US9878993B2Jan 30, 2018

DNA-PK inhibitors for treatment of cancer

VERTEX PHARMA10 citations92
US9359380B2Jun 7, 2016

DNA-PK inhibitors

VERTEX PHARMA19 citations92
US9340557B2May 17, 2016

Substituted quinoxaline DNA-PK inhibitors

VERTEX PHARMA19 citations92
US9296701B2Mar 29, 2016

DNA-PK inhibitors

VERTEX PHARMA21 citations92
US10973830B2Apr 13, 2021

Substituted quinoxaline DNA-PK inhibitors

VERTEX PHARMA3 citations84
US10786512B2Sep 29, 2020

DNA-PK inhibitors

VERTEX PHARMA3 citations84
US10501439B2Dec 10, 2019

DNA-PK inhibitors

VERTEX PHARMA5 citations84
US10442791B2Oct 15, 2019

DNA-PK inhibitors

VERTEX PHARMA5 citations84
US10391095B2Aug 27, 2019

DNA-PK inhibitors

VERTEX PHARMA5 citations84
US10258627B2Apr 16, 2019

DNA-PK inhibitors

VERTEX PHARMA4 citations84
US10076521B2Sep 18, 2018

DNA-PK inhibitors

VERTEX PHARMA7 citations84
US9987284B2Jun 5, 2018

Substituted benzooxadiazole DNA-PK inhibitors

VERTEX PHARMA5 citations84
US8354419B2Jan 15, 2013

Benzimidazole analogues for the treatment or prevention of flavivirus infections

VERTEX PHARMA10 citations82
US11884672B2Jan 30, 2024

Modulators of alpha-1 antitrypsin

VERTEX PHARMA4 citations70
US8779156B2Jul 15, 2014

Analogues for the treatment or prevention of flavivirus infections

VERTEX PHARMA7 citations70
US11623924B2Apr 11, 2023

Modulators of alpha-1 antitrypsin

VERTEX PHARMA3 citations68
US12251387B2Mar 18, 2025

Substituted quinoxalines and benzo[c][1,2,5]oxadiazoles as DNA-PK inhibitors

VERTEX PHARMA0 citations62
US11813267B2Nov 14, 2023

DNA-PK inhibitors

VERTEX PHARMA0 citations62
US11021465B2Jun 1, 2021

DNA-PK inhibitors

VERTEX PHARMA0 citations62
US11008305B2May 18, 2021

DNA-PK inhibitors

VERTEX PHARMA0 citations62
US12331057B2Jun 17, 2025

Modulators of alpha-1 antitrypsin

VERTEX PHARMA1 citations60
US8912326B2Dec 16, 2014

Process of making gyrase and topoisomerase inhibitors

VERTEX PHARMA0 citations51
US8765731B2Jul 1, 2014

Benzimidazole analogues for the treatment or prevention of flavivirus infections

VERTEX PHARMA1 citations50
US12502376B2Dec 23, 2025

Pyrano[4,3-b]indole derivatives as alpha-1-antitrypsin modulators for treating alpha-1-antitrypsin deficiency (AATD)

VERTEX PHARMA0 citations48

SHANNON DEAN

1 patent